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Background: Total knee arthroplasty (TKA) has been reported to be the most successful treatment for patients
with advanced osteoarthritis, however, early postoperative pain has become an unresolved issue. The aim of this
Meta-analysis is to evaluate the efficacy and safety of steroid addition to multimodal cocktail periarticular injection
(MCPI) in patients undergoing TKA.
Method: Clinical randomized controlled trials concerning the efficacy and safety of MCPI containing steroids in
TKA published up to December 2014 were retrieved from PubMed, Cochrane library, EMbase databases. The
methodological quality of the included studies was assessed by the 12-item scale. Data analysis was performed
using StataSE12.0.
Results: Six randomized controlled trials involving a total of 567 patients were assessed; the steroid group included
305 patients, and the control group included 262 patients. The meta-analysis showed that MCPI with steroids in TKA
significantly reduced postoperative pain; duration of time required to perform straight-leg raising and length of hospital
stay was (P < 0.05). Neither the early postoperative nor the long-term range of motion of knee showed any statistical
difference between the non-steroid and steroid group (P >0.05). For safety, steroids did not increase the incidence of
postoperative infection and wound oozing (P >0.05); no tendon rupture was reported up to now. In addition, steroids
did not decrease the postoperative drainage through the reduction of prostaglandins (P >0.05).
Conclusion: For patients undergoing TKA, the addition of steroids to MCPI improved the analgesic effect and was
proved to be highly safe. The duration of time required to perform straight-leg raising and length of hospital stay was
significantly reduced. However, MCPI with steroids neither increased the early postoperative range of motion (ROM) or
the long-term ROM of knee, nor did it reduce the postoperative drainage. However, the best results are acquired
in patients without any altered immunological status.
Keywords: Total knee arthroplasty, Steroid, Periarticular injection, Meta-analysisBackground
Total knee arthroplasty (TKA) has been reported to be
the most successful treatment for patients with advanced
osteoarthritis; however, the early postoperative pain has
become an unresolved issue [1]. Statistically, postopera-
tive pain following TKA is severe in approximately 60 %
of patients and moderate in approximately 30 %. Many
patients gave up TKA as they were concerned about the* Correspondence: lbchen@whu.edu.cn
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unless otherwise stated.postoperative pain [2]. Good postoperative analgesia im-
proves patient satisfaction, facilitates earlier rehabilitation,
reduces length of hospital stay, and decreases potential for
postoperative complications like deep vein thrombosis or
pneumonia [3]. Although good pain relief could be
achieved by continuous epidural anesthesia, femoral nerve
block, and patient controlled analgesia, the side effects are
quite worrisome. It includes muscle weakness, haematoma,
respiratory depression, urinary retention, nausea, and
vomiting which are all unfavorable for early rehabilitation
and increases chances for venous thromboembolism [4, 5].
Results from recent studies indicated that multimodalhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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shown good postoperatively pain relief, improvement in
range of motion (ROM) and reduction of postoperative
complications [6]. However, there is no gold-standard
protocol for the drug composition and quantity of the
cocktail injection. Recent studies have suggested that the
addition of steroids to MCPI might decrease the local in-
flammatory response following surgical trauma. Thereby
it resulted in decreased edema and blood loss owing to
the reduced production of prostaglandins which causes
vasodilation. Moreover, the patients may also enjoy a
permanently better ROM as steroids reduce the post-
operative fibrosis and scarring [7–9]. However, many
surgeons refrain from using periarticular steroids as
there is a possible complication of postoperative infec-
tion and patellar tendon rupture [10].
Recently, several randomized controlled trials (RCTs)
have compared the efficacy of MCPI with or without ste-
roids in TKA, but the conclusions were controversial.
Ikeuchi et al. [11] reported that MCPI with steroids re-
sulted in significant early pain relief and rapid recovery
in TKA. Kown et al. [12] observed that it just had an
additional pain-relieving effect on the night of the oper-
ation. However, Christensen et al. [10] stated that
MCPI with steroids can only reduce the length of the
hospital stay following TKA, but it appears to improve
neither pain relief nor ROM in the early postoperative
period. Until now, no meta-analysis in this field has
focused on it. Thus we undertook a meta-analysis to
evaluate the efficacy and safety of the addition of ste-




The PubMed, Embase, and the Cochrane Central Regis-
ter of Controlled Trials were searched from their earliest
entries up to December, 2014. The search strategy was
(((((((((random*[Title/Abstract]) OR “Randomized Con-
trolled Trial” [Publication Type])) AND (((“Arthroplasty,
Replacement, Knee”[Mesh]) OR ((((knee arthroplasty[Ti-
tle/Abstract]) OR knee replacement[Title/Abstract]) OR
knee replacements[Title/Abstract]) OR knee prosthesis[-
Title/Abstract])))))))))) AND (((((((“Steroids”[Mesh]) OR
((steroid[Title/Abstract]) OR corticosteroid[Title/Ab-
stract])))))) OR ((“Glucocorticoids”[Mesh]) OR gluco-
corticoid [Title/Abstract])). The reference list of the
relevant literatures were also reviewed manually for any
further relevant studies. Languages were not restricted
in this search.
Inclusion criteria and exclusion criteria
Inclusion criteria were as follows: (1) The target popula-
tion consisted of patients undergoing unilateral primaryTKA; (2) The interventional group should merely have
a steroid in addition to the control group; (3) The out-
comes were analyzed with respect to visual analogue
scale (VAS), ROM of knee, postoperative drainage, dur-
ation of time required to perform a straight-leg raise
(SLR), length of hospital stay, incidence of complica-
tions such as postoperative infection, and wound ooz-
ing; (4) The methodological criterion was prospective
RCT.
Exclusion criteria were as follows: (1) Patients under-
going bilateral TKA, unicondylar knee arthroplasty or
revision; (2) Other difference between the steroid group
and control group besides the administration of steroids;
(3) Animal studies.Date extraction and assessment of methodological quality
After the consecutive procedures of screening of titles and
abstracts, obtaining the full text of each article and review-
ing them, articles that met the eligibility criteria and did
not meet the exclusion criterias were selected to be in-
cluded. Data were extracted and collated independently by
two authors (ZXY and QJ), including author, published
year, sample size, patient age, sex, body mass index, drug
composition and quantity of the cocktail, injection method,
other intervention protocol, and the aforementioned
outcome indexes. The data of a published updated study
involving the same cohort of patients was extracted syn-
thetically. The original investigators were contacted when
requisite data were lacking in the publications. The meth-
odological quality of each included RCT was assessed by
two observers independently by the 12-item scale [13];
trials with a score of seven or more were considered high
quality, more than four but less than seven was considered
moderate quality, and less than four was considered low
quality. Disagreements were evaluated by the means of
kappa text and were resolved by discussing with the corre-
sponding author (CLB).Statistical methods
The meta-analysis was conducted with StataSE12.0 soft-
ware. The weighted mean difference (WMD) and 95 %
confidence interval (CI) were calculated for continuous
data, and the relative risk (RR) and 95 %CI were calculated
for dichotomous data. The statistical heterogeneity was
tested with the chi-square test and I2. If heterogeneity was
low (P > 0.1, I2 < 50 %), a fixed-effects model was used. If
heterogeneity was significant (P < 0.1, I2 > 50 %), sensitiv-
ity analysis and subgroup analyses were conducted to find
the source of the heterogeneity. If the heterogeneity could
not be eliminated, a random-effects model would be used
when the result of meta-analysis had clinical homogeneity,
or a descriptive analysis would be used.
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No external funding was received in support of this study.Results
Study characteristics
A total of 71 potential articles were identified and
screened for the meta-analysis. After screening of titles
and abstracts, obtaining the full text of each article and
reviewing them, six RCTs were selected for this meta-
analysis [10–12, 14–16] (Fig. 1). The cumulative sample
size of 567 unilateral primary TKA comprised of 305
with steroids and 262 without steroids. All cases were
successfully followed up except one patient in the steroid
group who died 25 days postoperatively as a result of
complications associated with deep knee-joint sepsis.
The main characteristics of the included studies were
summarized in Table 1, and the literature-exclusion pro-
cedure was depicted in Fig. 1. The methodological qual-
ity of the included RCTs was assessed with the 12-item
scale (Table 2); the results showed that the average score
for the quality of included studies was 11.67 ± 0.52, and
all RCTs were of high quality.Postoperative VAS
Pain score was assessed by VAS on the operative night,
and at postoperative days 1, 2, 3, and 7 in 5 [10–12, 14,
15] of the 6 studies. The results of the meta-analysis on
the operative night and postoperative day one appeared
heterogeneous (P < 0.1, I2 > 50 %); sensitivity analysis
did not detect the source of heterogeneity, and subgroup
analyses divided by possible diversity failed to eliminate
the heterogeneity. Then we found that, regardless of the
exclusion or inclusion of every study, the results were allFig. 1 Flow chart summarizing the selection process of randomized controthe same and had clinical agreement, so we conducted
the meta-analysis by the random-effects model for the
reason that all studies were of high quality. The fixed-
effects model was used in the rest postoperative period
as heterogeneity was not detected (P > 0.1, I2 < 50 %).
The pooling results indicated that the VAS at postopera-
tive days 2, 3, and 7 of the steroid group were signifi-
cantly lower than those of the control group (P < 0.05,
Table 3); however, no statistical difference of VAS on the
operation night and at postoperative day one was de-
tected between the two groups (P > 0.05, Table 3).Postoperative ROM
ROM at postoperative days 1, 2, 3, and month 3 was
reported in four of the six studies [10, 12, 14, 15].
Heterogeneity was detected in every postoperative period.
Sensitivity analysis and subgroup analysis failed to elimin-
ate the heterogeneity. The random-effects model was se-
lected for the reason that no matter what the exclusion or
inclusion of every study, the results were all the same and
had clinical agreement. The results of meta-analysis
showed that the ROM of knee at postoperative days 1, 2,
3, and month 3 did not show any significant difference be-
tween the steroid group and the control group (P > 0.05,
Figs. 2, 3, 4, and 5).Postoperative drainage
Three papers [11, 12, 15] including 146 patients in the
steroid group and 146 patients in the control group de-
scribed the postoperative drainage; a fixed-effects model
was used as no heterogeneity was detected (P = 0.199,
I2 = 38.1 %). The pooling result showed no statistical
difference of postoperative drainage between the twol trials




















Kwon 2014 76 69.3 0/76 25.9 76/76 ?/none/SA 10 mg morphine, 300 mg
ropivacaine,30 mg ketorolac,
300 μg of 1:1000 epinephrine
40 mg
Triamcinolone







Yue 2013 72 69.75 8/64 25.685 36/36 All drains/
none/GA
0.75 % ropivacaine 30 ml,






Ikeuchi 2014 40 76.5 6/34 ? 20/20 All drains/
none/GA
20 ml of 0.75 % ropivacaine,










Chia 2013 127 66.93 ? 31.15 84/43 None/none/
SA
0.2 % ropivacaine and 100 ml
1:1000 adrenaline








Seah 2011 100 66.65 ? 27 50/50 ?/none/SA or
GA
0.5 ml/kg of 1:200,000




SLIA IAPC Cemented TKA,
Postoperative
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Christensen 2009 76 65.508 23/53 33.9 39/37 ?/FNB/GA 80 mg of bupivacaine, 4 mg
morphine, 300 mg
epinephrine, 100 mg
clonidine, 750 mg cefuroxime
40 mg
Methylprednisolone



















Table 2 12-item scale critical appraisal scores
Author 12-item scale critical appraisal score
1 2 3 4 5 6 7 8 9 10 11 12 Total
Kwon 2014 [12] Y Y Y Y Y Y Y Y Y Y Y Y 12
Yue 2013 [14] Y Y Y Y Y Y Y Y Y Y Y Y 12
Ikeuchi 2014 [11] Y Y Y Y Y Y Y Y Y Y Y Y 12
Chia 2013 [16] Y Y Y Y Y Y Y Y Y Y Y Y 12
Seah 2011 [15] Y Y Y N Y Y Y Y Y Y Y Y 11
Christensen 2009 [10] Y Y Y Y N Y Y Y Y Y Y Y 11
12-item scale criteria: (1) Method of randomization; (2) Concealed allocation;
(3) Patient blinding; (4) Provider blinding; (5) Outcome assessor blinding; (6)
Drop-out rate; (7) Patient allocated as plan; (8) Free of selective outcome
reporting; (9) Same baseline; (10) Co-interventions avoided or similar; (11)
Acceptable compliance; (12) Same time of outcome assessment. Y = Yes,
N = No, A trial with a score of seven or more was considered high quality,
more than four but no more than seven was considered moderate quality,
and no more than four was considered low quality
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P = 0.453, Fig. 6).Period of time required to perform a straight-leg raise
The period of time required to perform a straight-leg
raise was reported in two [12, 15] of the six papers,
including 126 patients in the steroid group and 126
patient in the control group. The fixed-effects model
was selected as no significant heterogeneity was found
(P = 0.669, I2 = 0 %). The result of meta-analysis indi-
cated that patients in the steroid group could perform
a straight-leg raise significantly earlier than those in the
control group (WMD = −0.590, 95 % CI, −0.829 ~ −0.351,
P < 0.001, Fig. 7).Length of hospital stay
The length of hospital stay was recorded in two studies
[10, 15] including 89 patients in the steroid group and
87 patients in the control group. The fixed-effects model
was used as no heterogeneity was detected (P = 0.359,
I2 = 0 %). The results of meta-analysis indicated that
the length of hospital stay of the steroid group wasTable 3 Comparison of postoperative pain VAS scores between the
Postoperative
period
Weighted mean of VAS
in the steroid group
Weighted mean of VAS





Day 1 3.362 3.805 −0.630
Day 2 2.354 2.865 −0.300
Day 3 2.394 2.882 −0.568
Day 7 2.264 2.693 −0.310significantly shorter than that of the control group
(WMD = −1.032, 95 % CI, −1.618 ~ −0.447, P < 0.001,
Fig. 8).Incidence of complications
All six studies [10–12, 14–16] reported the incidence
of complications such as postoperative infection and
wound oozing. The fixed-effects model was selected,
respectively, as no significant heterogeneity was found
in the results of these two indexes (P > 0.1, I2 < 50 %).
The pooling results manifested that the incidence of
postoperative infection had no statistical difference be-
tween the steroid group and control group (RR = 1.632,
95 % CI, 0.299 ~ 8.900, P = 0.571, Fig. 9) and neither
did the incidence of wound oozing (RR = 1.241, 95 %
CI: 0.423 ~ 3.641, P = 0.694, Fig. 10). For RCTs in our
study, the inclusion criteria for four of all six were
patients undergoing primary TKA for osteoarthritis;
patients with co morbidities resulting in altered im-
munological status such as history of uncontrolled
diabetes mellitus, immunocompromised renal failure,
ipsilateral deep-knee infection, and hypersensitivity to
one or more drugs included in the cocktail; major psy-
chological ailments or any other systemic conditions
which is even a contraindication for a normal TKA
were excluded from all the RCTs.Discussion
MCPI has been particularly effective in relieving
pain, enabling earlier rehabilitation, and improving
postoperative ROM, meanwhile, it reduces the com-
plications of other pain management modalities such
as continuous epidural anesthesia, femoral nerve
block, and patient controlled analgesia [1, 2, 17, 18].
However, the drug composition and quantity of
MCPI still has no gold-standard protocol. Considering the
efficacy of steroids in decreasing the local inflammatory
response following surgical trauma and reducing the
postoperative fibrosis and scarring, several RCTssteroid and control group
[95 % CI] P of heterogeneity I2 Selected model Overall P
−0.914 0.258 0.006 80.3 % Random-effects
model
0.272
−1.321 0.061 0.001 87.1 % Random-effects
model
0.074
−0.504 −0.096 0.249 28.0 % Fixed-effects
model
0.004
−0.868 −0.268 0.194 36.3 % Fixed-effects
model
0.001
−0.496 −0.125 0.520 0 % Fixed-effects
model
<0.001
Fig. 2 Comparison of knee ROM between the steroid and control group at the first postoperative day
Fig. 3 Comparison of knee ROM between the steroid and control group on the second postoperative day
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Fig. 4 Comparison of knee ROM between the steroid and control group on the third postoperative day
Fig. 5 Comparison of knee ROM between the steroid and control group at 3 months postoperatively
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Fig. 6 Comparison of postoperative drainage between the steroid and control group
Fig. 7 Comparison of the period of time required to perform a straight-leg raise between the steroid and control group
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Fig. 8 Comparison of the length of hospital stay between the steroid and control group
Fig. 9 Comparison of the rate of postoperative infection between the steroid and control group
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Fig. 10 Comparison of the rate of postoperative wound oozing between the steroid and control group
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roids have been published, but these studies pointed
to different end results [9–12, 14–16, 19]. Although
the existing RCTs have confirmed the safety of ste-
roids, many surgeons still hesitate to use a drug
which is thought to increase the risk of catastrophic
complications like infection and patellar tendon rup-
ture [20–23].
The results of this meta-analysis indicated that the
addition of steroids might not further improve the an-
algesic efficacy of MCPI in the hyperacute phase,
which included the operative night and postoperative
day one. However, the application of steroids signifi-
cantly relieved the postoperative pain after that phase,
reducing the time required to perform a straight-leg
raise and length of hospital stay. As the included RCTs
in our study only evaluated the efficacy of steroids in
MCPI, the pooling results of our study proved that
steroids could further improve the analgesic effect of
MCPI. The suppression of inflammatory reaction by
periarticular steroid administration is explained by the
cascade inhibiting the cytoactivity of immunocytes by
blocking the synthesis of phospholipase A2 and
thereby reducing the production of inflammatory media-
tors and cytokines [7]. Ng et al. [19] and Ikeuchi et al. [11]
reported the local and systemic anti-inflammatoryeffects of steroids, which were supported by evaluating
interleukin-6 in drain fluid and serum C-reactive pro-
tein. The forest plot of the seventh postoperative day
showed a better analgesic effect for the steroid group,
which made us believe that MCPI with steroids pro-
vided prolonged analgesic effects which could be
maintained for at least seven days. It also supported
the possibility of steroids itself playing a pivotal role,
as the effect of local anesthetics should have had
already disappeared by that time.
The forest plots demonstrate that neither the early
postoperative ROM nor the long-term ROM of knee
showed any difference between the non-steroid and
steroid group. For the reason that TKA is a major
trauma, the analgesic effect is insufficient for a better
ROM during the early postoperative period even if an
earlier straight-leg rise and a shorter length of hospital
stay are achieved by MCPI with steroids. There is no
statistical difference in ROM between steroid and
non-steroid group at the third postoperative month,
which means MCPI with steroids, might not increase
the ROM as it does not decrease postoperative fibrosis
and scarring at the respective time frame.
For safety, many surgeons refrain from using peri-
articular steroids, concerned about the risk of postop-
erative infection and wound problems [24, 25]. Among
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for four of all six were patients undergoing primary
TKA for osteoarthritis. Almost all the RCTs excluded
patients with a past history of uncontrolled diabetes
mellitus, immunocompromised renal failure, ipsilateral
deep-knee infection, and hypersensitivity to one or
more drugs included in the cocktail, major psycho-
logical ailments or any other systemic conditions
which is even a contraindication for a normal TKA
[10–12, 14–16]. The result of our meta-analysis indi-
cated that the steroid addition to MCPI would not
increase the incidence of postoperative infection and
wound oozing; moreover, no tendon rupture was
reported in the included studies. All these results sug-
gest that the drug composition and amount of steroids
in the included studies did not increase the risk of
postoperative infection and wound problems. Although
existing studies have not demonstrated a significant
increase in the incidence of such catastrophic com-
plications, MCPI with steroids should be best used
in patients undergoing primary TKA for osteoarthritis;
patients with a history of aforementioned ailments
should be excluded [11].
In spite of previous studies which presumed that
MCPI with steroids might decrease the blood loss due
to a reduction in the production of prostaglandins
with vasodilatory effects [11, 12, 15], the result of our
meta-analysis showed that it could not significantly re-
duce the postoperative drainage. One thing to note
here is that postoperative drainage only represents ob-
vious blood loss; whether the total blood loss is re-
duced due to MCPI with steroids is still unknown. For
this reason, RCTs which evaluate the changes of
hemoglobin level should be performed as the existing
data could not assess the changes of hidden and total
blood loss by meta-analysis.
The limitations of our study include the following. (1)
The meta-analysis of ROM and some postoperative VAS
appeared heterogeneous, and sensitivity analysis and
subgroup analyses failed to eliminate the heterogeneity.
As those results of meta-analysis had clinical agreement,
we included all those studies and conducted the meta-
analysis by the random-effects model for the reason that
those studies were of high quality, which may slightly in-
fluence the reliability of the meta-analysis. (2) The in-
cluded studies were lacking in, inflammation evaluating
indexes like interleukin-6, serum C-reactive protein, and
erythrocyte sedimentation rate, so we could not evaluate
the efficacy of MCPI with steriod comprehensively.
Conclusions
For patients undergoing TKA, the addition of steroids,
which is proved to be highly safe, further improves the
analgesic efficacy of MCPI. MCPI with steroids mightneither increase the early or long-term postoperative
ROM of knee nor may it reduce the postoperative drain-
age. However, the duration of time required to perform
straight-leg raising and length of hospital stay are re-
duced. However, the best results are acquired in patients
without any altered immunological status. New RCTs
which evaluate the changes in hematocrit levels and
those which incorporate knee-score system should be
performed for the purpose of evaluating the efficacy of
MCPI with steriod comprehensively.
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